SUMMER 2022 AGENDA

TUESDAY, JUNE 28, 2022

All Times are EST Time Zone
 

8:30am // REGISTRATION AND BREAKFAST

9:00am // OPENING REMARKS - Angus McQuilken, Industry Relationship Executive - Life Sciences, McDermott Will & Emery. Bill Werkmeister, Partner, MedInvest Conferences

9:10am // KEYNOTE TALK - Dr. Keith Flaherty, Co-Founder of Loxo Oncology | Director of Clinical Research at the Massachusetts General Hospital. Topic: Precision Oncology.

9:40am // Corporate Presentation - Apricity Health

10:00am // Corporate Presentation - Genomic Expression

10:20am // Corporate Presentation - Sanavia Oncology

10:40am // Corporate Presentation - Impact Therapeutics

11:00am // Corporate Presentation - NKore Biotherapeutics

11:20am // Corporate Presentation - Siva Therapeutics
11:40pm // Corporate Presentation - Pacylex Pharmaceuticals

12:00pm // Corporate Presentation - Aravive

12:20pm // TALK - Kunal Bhatia, Director Healthcare Banking at Cowen and Bill Kadel, Vice President Equity Capital Markets at Cowen.  Topic: Biotechnology Capital Markets Update.

12:50pm // LUNCH - Workshop

1:00pm - 2:30pm // CEO WORKSHOP - Achieving Commercial Success with the NIH as a Strategic Partner. Curators: Dr. Michael Salgaller, Director of Tech Transfer, NCI | Supervisor, Invention Development and Marketing Unit (IDMU); Steve Ferguson, Deputy Director, Licensing and Entrepreneurship, National Institutes of Health

2:10pm // Corporate Presentation - BAKX Therapeutics

2:30pm // Corporate Presentation - Oncoxome

2:50pm // Corporate Presentation - NexPlasmaGen

3:10pm // Corporate Presentation - Concarlo Therapeutics

3:30pm // Corporate Presentation - ExoProTher Medical

3:50pm // Corporate Presentation - Kintara Therapeutics

4:10pm // Corporate Presentation - SciTech Development

4:30pm // Corporate Presentation - SmartScan

4:50pm // Corporate Presentation - TRIO Pharmaceuticals

5:10pm // PANEL DISCUSSION: Cellular Therapy. Dr. Phil Friedlander, Professor, Mt. Sinai |Chief Investigator, Iovance; Dr. Alfred Slanetz, CEO, Geneius | Board, NFCR | Former CEO, Bluebird Bio

5:40pm // CLOSING REMARKS

5:50pm // DINNER RECEIPTION

WEDNESDAY, JUNE 29, 2022

All Times are EST Time Zone
 

8:30am // REGISTRATION AND BREAKFAST

9:00am // OPENING REMARKS 

9:10am // KEYNOTE TALK - Dennis Purcell, Founder Aisling Capital. Topic: What's Next for Biotech

9:40am // Corporate Presentation - Stellarray

10:00am // Corporate Presentation - 20/20 Gene Systems

10:20am // Corporate Presentation - Lantern Pharma

10:40am // Corporate Presentation - CytImmune Sciences

11:00am // Corporate Presentation - SmartBreast

11:20am // Corporate Presentation - Rapa Therapeutics

11:40am // Corporate Presentation - SynDevRx
12:00pm // Corporate Presentation - Canget BioTekpharma

12:20pm // TALK - Dr. Niels Emmerich, Global Head of Search and Evaluation, Abbvie.  Topic: Abbvie Oncology Pipeline

12:50pm // LUNCH - Workshop

1:00pm - 2:30pm // CEO WORKSHOP - From Horrors to Triumphs - Startup and Growth Fundraising. Curator: Dr. Michael Weickert, CEO of Pacylex Pharmaceuticals | CEO of Fe Pharmaceuticals | 30 Years of Drug and Med Device Development

2:30pm // Corporate Presentation - Revere Pharmaceuticals

2:50pm // Corporate Presentation - Rampart Health

3:10pm // Corporate Presentation - Early Detection

3:30pm // Corporate Presentation - SIWA Therapeutics

3:50pm // Corporate Presentation - Amplified Sciences

4:10pm // Corporate Presentation - KAHR Bio

4:30pm // Corporate Presentation - Geneius Biotechnology

4:50pm // TALK - Dr. Brian Lelyand-Jones, CMO NFCR | Former Director of McGill and Emory Cancer Centers. Topic: The Future of Cancer Care: patient-centric, multi-omic, multi-modality therapy, digital, implantables.

5:20pm // CLOSING TALK - Todd Kornfeld, Partner, McDermott Will & Emery. Topic: The State of Capital Markets for Life Sciences Startups and Alternatives to Consider.

5:50pm // CLOSING REMARKS

6:00pm // COCKTAIL RECEPTION